Align Technologyvs.Boston Scientific
ALGN vs BSX · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices, from surgery and cardiology to robotics.
Boston Scientific is about 6.1× larger than Align Technology by market cap; Boston Scientific trades at the lower P/E (16.7 vs 24.4); year to date, Align Technology leads (−10.4% vs −55.9%).
Side by side
| ALGN | BSX | |
|---|---|---|
| Market cap | $10.1B | $61.2B |
| Price | $142.71 | $42.73 |
| Today | +1.2% | +1.6% |
| Return YTD | −10.4% | −55.9% |
| Return 1Y | +7.2% | −56.6% |
| Since June 26, 2026 | −20.0% | −3.4% |
| P/E | 24.4 | 16.7 |
| P/S | 2.4 | 2.9 |
| P/B | 2.4 | 2.5 |
Data as of 2026-10-09 · updates daily after U.S. close
Since June 26, 2026: the change in the closing price, from the daily closes Sectivia records itself since that date.
The two companies
Align TechnologyALGN
Invisalign clear aligners, backed by digital dental scanning.
Full ALGN profile →Boston ScientificBSX
Cardiology drives the growth, particularly electrophysiology, where Farapulse sits, and structural heart treatment. Endoscopy and urology cover the rest of the range.
Full BSX profile →More ALGN & BSX comparisons
Other head-to-heads in the Medtech & devices segment.